Randal Scott W.'s most recent trade in BridgeBio Pharma Inc was a trade of 8,425 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 11,589 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 03 Jun 2024 | 1,500 | 4,000 (0%) | 0% | 31.3 | 46,950 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 28.68 per share. | 03 Jun 2024 | 800 | 5,700 (0%) | 0% | 28.7 | 22,948 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 29.48 per share. | 03 Jun 2024 | 200 | 5,500 (0%) | 0% | 29.5 | 5,895 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 01 Mar 2024 | 2,500 | 6,500 (0%) | 0% | 34 | 85,000 | Common Stock |
| BridgeBio Pharma Inc | Randal Scott W. | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 18 Dec 2023 | 2,000 | 9,000 (0%) | 0% | 40 | 80,000 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 01 Dec 2023 | 1,500 | 11,000 (0%) | 0% | 30 | 45,000 | Common Stock |
| BridgeBio Pharma Inc | W. Scott Randal | Director | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 01 Dec 2023 | 1,000 | 12,500 (0%) | 0% | 28.5 | 28,500 | Common Stock |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 95,000 | 95,000 | - | - | Stock option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 86,705 | 86,705 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 161,222 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 45,325 | 82,325 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 22,730 | 22,730 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 8,475 | 90,800 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 4,275 | 4,275 | - | - | Employee Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 95,000 | 95,000 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 38,895 | 38,895 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Randal W. Scott | Director | Purchase of securities on an exchange or from another person at price $ 10.11 per share. | 14 May 2021 | 11,000 | 20,000 | - | 10.1 | 111,210 | Common stock |
| Talis Biomedical Corp | Randal W. Scott | Director | Purchase of securities on an exchange or from another person at price $ 10.16 per share. | 14 May 2021 | 9,000 | 9,000 | - | 10.2 | 91,440 | Common stock |
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 1,076,643 | 0 | - | - | Series D-1 Preferred Stock | ||
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 752,897 | 752,897 | - | - | Common Stock | ||
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 478,402 | 0 | - | - | Series E-1 Preferred Stock | ||
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 432,749 | 0 | - | - | Series F-1 Preferred Stock | ||
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 334,546 | 1,087,443 | - | - | Common Stock | ||
| Talis Biomedical Corp | Randal W. Scott | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 17 Feb 2021 | 312,500 | 312,500 | - | 16 | 5,000,000 | Common Stock |
| Talis Biomedical Corp | Randal W. Scott | Director | 17 Feb 2021 | 302,621 | 1,390,064 | - | - | Common Stock | ||
| BridgeBio Pharma Inc | Randal W. Scott | Director | Purchase of securities on an exchange or from another person at price $ 62.50 per share. | 17 Feb 2021 | 16,000 | 21,000 (0%) | 0% | 62.5 | 1,000,000 | Common Stock |